Catalyst Wire Dossier Catalyst Wire Dossier

Telaprevir (Incivek)

telaprevir · Vertex Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Telaprevir (Incivek), covering 2015-03-06 to 2015-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1 [Phase 2]

See pricing